SII to focus on supplying vaccine to India first
The Serum Institute of India, the world’s largest manufacturer of vaccines by volume, will first focus on supplying AstraZeneca Plc’s COVID-19 vaccine to Indians before distributing it to other countries, Serum’s Chief Executive Adar Poonawalla said on Monday.”It’s very important we take care of our country first, then go on to COVAX after that and then other bilateral deals with countries. So I’ve kept it in that priority,” said Poonawalla, referencing the global COVAX facility, which has been set up to provide COVID-19 vaccines to poorer countries.The company remains in discussion with the Indian government about inking a purchase agreement for…
